Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Lentiviral gene therapy for X-linked chronic granulomatous disease
Kohn DB, Booth C, Kang EM, et al.
Nature medicine, 2020, 26, 2, p 200
Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer
Da Rocha S, Bigot J, Onodi F, et al.
Molecular therapy. Methods & clinical development, 2019, 14, p 285
Efficacité et sécurité du traitement par thérapie génique des patients atteints du syndrome de Wiskott-Aldrich
Galy A, Corre G, Cavazzana M, et al.
médecine/sciences, 2015, 31, 12, p. 1066-1069
Succès de thérapie génique pour la maladie de Wiskott-Aldrich : Interview de Anne Galy
AFM-Telethon, Galy A
2015
Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs
Molina-Estevez FJ, Nowrouzi A, Lozano M, et al.
Current gene therapy, 2015, 15, 6, p 550
Hypoxic culture conditions enhance the generation of regulatory T cells
Neildez-Nguyen TM, Bigot J, Da Rocha S, et al.
Immunology, 2015, 144, 3, p 431
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome
Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al.
JAMA. Journal of the American Medical Association, 2015, 313, 15, p 1550
Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
Ferrand M, Da Rocha S, Corre G, et al.
Molecular therapy, 2015, 23, 6, p 1022
A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer
Ferrand M, Galy A, Boisgerault F
Gene therapy, 2014, 21, 9, p 828
Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors
Holic N, Seye AK, Majdoul S, et al.
Human gene therapy. Clinical development, 2014, 25, 3, p 178
Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancers
Ingrao D, Majdoul S, Seye AK, et al.
Human gene therapy methods, 2014, 25, 1, p 48
Immunization of mice with lentiviral vector targeted to MHC class II+ cell is due to preferential transduction of dentritic cells in vivo
Ciré S, Da Rocha S, Yao R, et al.
PLoS ONE, 2014, 9, 7
Gene therapy on the move
Kaufmann KB, Buning H, Galy A, et al.
EMBO Molecular Medicine, 2013, 5, 11, p. 1642-1661
Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor
Charrier S, Blundell M, Cedrone G, et al.
Haematologica, 2013, 98, 8, p. 1300-1308
Prolonged gene expression in muscle is achieved without active immune tolerance using MicrorRNA 142.3p-regulated rAAV gene transfer
Boisgerault F, Gross DA, Ferrand M, et al.
Human gene therapy, 2013, 24, 4, p. 393-405
Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with HIV-1 based lentiviral vectors reveal different effects of transduction enhancers
Ingrao D, Majdoul S, Seye AK, et al.
Human gene therapy methods, 2013, Epub ahead of print
Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1
Fenard D, Genries S, Scherman D, et al.
Journal of virological methods, 2013, 189, 2, p. 375-378
Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells
Fenard D, Ingrao D, Seye A, et al.
Molecular therapy-nucleic acids, 2013, 2, p. e90
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients
Saliba J, Hamidi S, Lenglet G, et al.
PLoS ONE, 2013, 8, 9
The brown algae Pl.LSU/2 group II intron-encoded protein has functional reverse transcriptase and maturase activities
Zerbato M, Holic N, Moniot-Frin S, et al.
PLoS ONE, 2013, 8, 3, e58263
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
Aiuti A, Biasco L, Scaramuzza S, et al.
Science, 2013, 341, 6148, p. 1233151
Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1
Lafouresse F, Cotta-de-Almeida V, Malet-Engra G, et al.
2012, p. 183-196
MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV
Sudres M, Cirera S, Vasseur V, et al.
Molecular therapy, 2012, 20, 8, p. 1771-1781
Lentiviral transduction of CD34+ cells induces genome-wide epigenetic modifications
Yamagata Y, Parietti V, Stockholm D, et al.
PLoS ONE, 2012, 7, 11, e48943
